The order was received on December 30, 2025, and relates to the financial years 2018–19, 2019–20, 2021–22, and 2023–24. The penalty has been levied on account of the disallowance of Input Tax Credit (ITC) by the GST authorities.
The company made the disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as part of its statutory obligation to inform investors about material regulatory developments. Abbott India clarified that the action has been initiated by the GST tax authorities following assessment proceedings conducted by the jurisdictional office in Mumbai East.
According to the details shared by the company, the order alleges violations linked to the availment of input tax credit. However, Abbott India has stated that it does not agree with the findings of the tax authorities and believes that the demand raised through the order is not maintainable under law. The company has also emphasized that the penalty does not have any material impact on its financial position, business operations, or other corporate activities.
Abbott India further informed that it is in the process of preferring an appeal against the said order before the appropriate appellate authority. The company expressed confidence in its legal position and expects to receive relief through the appellate process.
The disclosure was submitted to BSE Limited, and has been duly signed by Sangeeta Shetty, Company Secretary, on behalf of Abbott India Limited. The company reiterated its commitment to regulatory compliance and stated that it will continue to take all necessary steps to protect its interests while following due legal process.
Abbott India Limited, which is headquartered at Godrej BKC, Bandra-Kurla Complex, Mumbai, has assured stakeholders that the development will not adversely affect its ongoing operations or financial stability.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.